Somna Therapeutics
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Somna Therapeutics
Deal Watch: Lilly Will Take Over Beam’s Rights To Verve Cardiovascular Assets
Lilly looks To Elektrofi for help on subcutaneous injectable therapies, while NAYA will merge with INVO and acquire two antibodies from Cytovia. Plus deals involving Hummingbird/Endeavor, Basilea/Gravitas/Intron, Lilly/Mablink and Sotio/Synaffix.
Regulatory News Briefs
A new refuse-to-accept guidance; FDA finalizes classification decisions; and the agency awards an emergency authorization for a new rapid Ebola assay.
Emergings In Brief, September 2012
Brief profiles of these recently formed companies: Aerial BioPharma, Intelligent Ultrasound, Melanovus Oncology, and Somna Therapeutics.
Out Of The Blocks, September 2012
Brief profiles of these recently formed companies: Aerial BioPharma, Intelligent Ultrasound, Melanovus Oncology, Q-Sera, Retia Medical, and Somna Therapeutics.
Company Information
- Industry
- Medical Devices
-
Medical Devices
- Consumables, Central Supplies
- Implantable Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Laser
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice